Top Markets
#1 Ontology Gas Ontology Gas +26.62%
#2 EXOD EXOD +22.08%
#3 Status Status +17.01%
#4 Derive Derive +8.72%
#5 Gas Gas +7.44%
#6 Fake World Assets Fake World Assets +6.08%
#7 aelf aelf +5.83%
#8 Tornado Cash Tornado Cash +5.44%
#9 B3 (Base) B3 (Base) +5.37%
#10 DeFi Kingdoms DeFi Kingdoms +5.13%
Coin of the day
Ontology Gas Ontology Gas
Settings
Language
ENGLISH
Currency
USD
Theme
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
Rank in Stocks #25837
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
Share Price
$0.74834668
Last synced: 2026-08-20
Market Cap
$45.86M
Change (1 day)
-0.15%
Change (1 year)
-2.71%
Country
SE
Trade Mendus AB (publ) (IMMU)

Category

Healthcare
Operating Margin for Mendus AB (publ) (IMMU)
Operating Margin as of 2026 TTM: 0.00%
According to Mendus AB (publ) latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Mendus AB (publ) from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.